QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:EGO

Eldorado Gold (EGO) Stock Price, News & Analysis

$15.04
+0.14 (+0.94%)
(As of 04:00 PM ET)
Today's Range
$14.84
$15.13
50-Day Range
$10.16
$15.66
52-Week Range
$8.30
$16.01
Volume
1.61 million shs
Average Volume
1.69 million shs
Market Capitalization
$3.07 billion
P/E Ratio
28.38
Dividend Yield
N/A
Price Target
$13.90

Eldorado Gold MarketRank™ Stock Analysis

Analyst Rating
Hold
2.14 Rating Score
Upside/​Downside
7.6% Downside
$13.90 Price Target
Short Interest
Healthy
2.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.05mentions of Eldorado Gold in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
3.90%
From $0.77 to $0.80 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.15 out of 5 stars

Basic Materials Sector

107th out of 172 stocks

Gold & Silver Ores Industry

13th out of 38 stocks

EGO stock logo

About Eldorado Gold Stock (NYSE:EGO)

Eldorado Gold Corporation, together with its subsidiaries, engages in the mining, exploration, development, and sale of mineral products primarily in Turkey, Canada, Greece, and Romania. The company primarily produces gold, as well as silver, lead, and zinc. It holds a 100% interest in the Kisladag and Efemçukuru mines located in Turkey; Lamaque complex located in Canada; and Olympias, Stratoni, Skouries, Perama Hill, and Sapes gold mines located in Greece, as well as the 80.5% interest in Certej development projects located in Romania. The company was formerly known as Eldorado Corporation Ltd. and changed its name to Eldorado Gold Corporation in April 1996. Eldorado Gold Corporation was incorporated in 1996 and is headquartered in Vancouver, Canada.

EGO Stock Price History

EGO Stock News Headlines

Eldorado Gold (EGO) to Release Quarterly Earnings on Thursday
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Eldorado Gold downgraded to Hold at Stifel ahead of earnings
New Strong Buy Stocks for January 26th
2024 Looks Promising for Eldorado Gold
See More Headlines
Receive EGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eldorado Gold and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/19/2024
Next Earnings (Confirmed)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Gold & silver ores
Sub-Industry
N/A
Employees
4,700
Year Founded
1992

Price Target and Rating

Average Stock Price Target
$13.90
High Stock Price Target
$20.00
Low Stock Price Target
$9.00
Potential Upside/Downside
-7.3%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Net Income
$104.63 million
Pretax Margin
16.20%

Debt

Sales & Book Value

Annual Sales
$1.01 billion
Cash Flow
$1.84 per share
Book Value
$17.16 per share

Miscellaneous

Free Float
202,679,000
Market Cap
$3.06 billion
Optionable
Optionable
Beta
1.10

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. George Raymond Burns (Age 64)
    President, CEO & Director
    Comp: $1.48M
  • Mr. Paul Ferneyhough
    CFO & Executive VP
  • Mr. Simon Oswald Hille
    Executive VP of Technical Services & Operations
  • Ms. Lynette Gould
    Vice President of Investor Relations, Communications & External Affairs
  • Mr. Frank Hamilton Herbert
    Executive VP, General Counsel & Chief Compliance Officer
  • Mr. Graham Morrison
    Vice President of Corporate Development
  • Ms. Claire Mary Chamberlain
    Vice President of Exploration
  • Mr. Per Niklas Frank
    Senior Vice President of Operations
  • Ms. Nora Lozano
    Vice President of Health, Safety & Sustainability
  • Mr. Ryan Swedburg
    Senior Vice President of Finance

EGO Stock Analysis - Frequently Asked Questions

Should I buy or sell Eldorado Gold stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eldorado Gold in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" EGO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EGO, but not buy additional shares or sell existing shares.
View EGO analyst ratings
or view top-rated stocks.

What is Eldorado Gold's stock price target for 2024?

7 Wall Street research analysts have issued 1-year price targets for Eldorado Gold's shares. Their EGO share price targets range from $9.00 to $20.00. On average, they anticipate the company's stock price to reach $13.90 in the next twelve months. This suggests that the stock has a possible downside of 7.6%.
View analysts price targets for EGO
or view top-rated stocks among Wall Street analysts.

How have EGO shares performed in 2024?

Eldorado Gold's stock was trading at $12.97 on January 1st, 2024. Since then, EGO shares have increased by 16.0% and is now trading at $15.04.
View the best growth stocks for 2024 here
.

Are investors shorting Eldorado Gold?

Eldorado Gold saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 5,880,000 shares, a decrease of 5.9% from the February 29th total of 6,250,000 shares. Based on an average trading volume of 1,590,000 shares, the short-interest ratio is currently 3.7 days. Approximately 2.9% of the company's stock are short sold.
View Eldorado Gold's Short Interest
.

When is Eldorado Gold's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our EGO earnings forecast
.

How can I listen to Eldorado Gold's earnings call?

Eldorado Gold will be holding an earnings conference call on Friday, April 26th at 11:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 604-638-9010 with passcode "0758".

How were Eldorado Gold's earnings last quarter?

Eldorado Gold Co. (NYSE:EGO) announced its quarterly earnings data on Thursday, February, 22nd. The basic materials company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.21 by $0.03. The basic materials company had revenue of $306.90 million for the quarter. Eldorado Gold had a trailing twelve-month return on equity of 3.56% and a net margin of 10.54%.

What ETF holds Eldorado Gold's stock?

Dimensional International Small Cap Value ETF holds 622,621 shares of EGO stock, representing 0.50% of its portfolio.

What is Paul N. Wright's approval rating as Eldorado Gold's CEO?

3 employees have rated Eldorado Gold Chief Executive Officer Paul N. Wright on Glassdoor.com. Paul N. Wright has an approval rating of 100% among the company's employees. This puts Paul N. Wright in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Eldorado Gold own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eldorado Gold investors own include Yamana Gold (AUY), Kinross Gold (KGC), Eldorado Gold (ELD), Barrick Gold (GOLD), First Majestic Silver (AG), AT&T (T), BioDelivery Sciences International (BDSI), Cisco Systems (CSCO), Advanced Micro Devices (AMD) and Newmont (NEM).

Who are Eldorado Gold's major shareholders?

Eldorado Gold's stock is owned by many different institutional and retail investors. Top institutional investors include Helikon Investments Ltd (13.57%), Equinox Partners Investment Management LLC (0.42%) and Banque Cantonale Vaudoise (0.00%).

How do I buy shares of Eldorado Gold?

Shares of EGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:EGO) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners